| Patent application number | Description | Published |
|---|
| 20110268428 | ACCELERATED PLAYBACK OF STREAMING MEDIA - One embodiment of the present invention provides a technique for dynamically adjusting streaming media bit rates in response to user requests for accelerated playback. When user may selects to accelerate playback of streaming media content, a content player may begin decoding data from a content buffer at the accelerated rate. At the same time, the content player may estimate a bit rate that can be supported by both the accelerated playback rate and prevailing network bandwidth and latency. That is, a bit rate at which the accelerated playback may be continued without resulting in an eventual buffer under-run. | 11-03-2011 |
| 20120042047 | System and Method For Synchronized Playback of Streaming Digital Content - One embodiment of the present invention sets forth a technique for synchronizing playback of digital content on two or more different content players. Each content player synchronizes a local time signal to a time reference signal maintained by a time server. Actions related to content playback are synchronized with respect to each local time signal for a given content player, which thereby synchronizes playback for a group of associated content players. Each content player may be advantageously configured with different playback options, allowing each user to have a better shared viewing experience than possible with prior art solutions that provide only one set of playback options. | 02-16-2012 |
| 20150110474 | ACCELERATED PLAYBACK OF STREAMING MEDIA - One embodiment provides a technique for dynamically adjusting streaming media bit rates in response to user requests for accelerated playback. A user request to increase a playback speed at which the units of digital content are played back on a content player is received. Upon receiving the user request to increase the playback speed, while previously downloaded units of the digital content having a first bit rate are being output for display, and prior to downloading a next unit of digital content from a content server, embodiments determine that the increased playback speed cannot be maintained without buffer underrun if subsequent units of digital content are downloaded from the content server at the first bit rate. A second bit rate, lower than the first bit rate, is determined and the next unit of digital content is downloaded from the content server for playback at the second bit rate. | 04-23-2015 |
| Patent application number | Description | Published |
|---|
| 20100104953 | PROCESS AND HARDWARE FOR PLASMA TREATMENTS | 04-29-2010 |
| 20130081301 | Stiction-free drying of high aspect ratio devices - A method of removing a water-comprising rinse/cleaning material from the surface of a device which includes high aspect ratio features (an aspect ratio of 5 or greater) where sidewalls of the feature are separated by 50 nm or less without causing stiction between the feature sidewall surfaces. The method relies on the use of a low surface tension drying liquid which also exhibits a high evaporation rate. The method also relies on a technique by which the drying liquid is applied. Increasing the evaporation rate of the drying liquid and application of the drying liquid in the form of a vapor helps to eliminate stiction. | 04-04-2013 |
| 20130089987 | Method of barc removal in semiconductor device manufacturing - A method of removing a high molecular weight organic-comprising hard mask or BARC from a surface of a porous low k dielectric material, where a change in the dielectric constant of the low k dielectric material is less than about 5% after application of the method. The method comprises exposing the organic-comprising hard mask or BARC to nitric acid vapor which contains at least 68% by mass HNO | 04-11-2013 |
| 20130302595 | SUPER-HYDROPHOBIC AND OLEOPHOBIC TRANSPARENT COATINGS FOR DISPLAYS - Embodiments described herein generally relate to methods of creating super-hydrophobic and super-oleophobic layers and the resulting composition of matter. A method for creating a super-hydrophobic and super-oleophobic surface can include positioning a substrate with an exposed surface in a processing chamber, injecting an electrically charged silicon-containing deposition material towards the surface of the substrate, depositing silicon-containing nanofibers onto the exposed surface of the substrate, and depositing a thin low surface energy layer over the exposed surface of the substrate and the silicon-containing nanofibers. A substrate with a super-hydrophobic and super-oleophobic surface can include a substrate with an exposed surface, one or more layers of nanofibers disposed on the exposed surface, and a thin low surface energy material deposited over both the nanofibers and the exposed surface. | 11-14-2013 |
| 20140144462 | STICTION-FREE DRYING PROCESS WITH CONTAMINANT REMOVAL FOR HIGH-ASPECT RATIO SEMICONDUCTOR DEVICE STRUCTURES - Embodiments of the invention generally relate to a method of cleaning a substrate and a substrate processing apparatus that is configured to perform the method of cleaning the substrate. More specifically, embodiments of the present invention relate to a method of cleaning a substrate in a manner that reduces or eliminates the negative effects of line stiction between semiconductor device features. Other embodiments of the present invention relate to a substrate processing apparatus that allows for cleaning of the substrate in a manner that reduces or eliminates line stiction between semiconductor device features formed on the substrate. | 05-29-2014 |
| Patent application number | Description | Published |
|---|
| 20140278917 | Systems and Methods for Creating Product Advertising Campaigns - Systems and methods for creating product advertising campaigns in accordance with embodiments of the invention are disclosed. In one embodiment, a product target generation server system includes a processor, product data including a plurality of attribute-value pairs describing a set of products, semantic models including data describing relationships between product targets, concepts described using categories and attribute-value pairs, and target grouping data constituting a set of groupings of product targets, global performance data including performance data, wherein the processor is configured to identify at least one category in a portion of the product data, determine a product advertising structure based on the product data and the identified at least one category, match a portion of the groupings of product data with the product targets within the global performance data, identify performance data, and generate at least one product target using the identified performance data and the product data. | 09-18-2014 |
| 20140279037 | Systems and Methods for Creating Product Advertising Campaigns - Systems and methods for creating product advertising campaigns in accordance with embodiments of the invention are disclosed. In one embodiment, a product target generation server system includes a processor, product data including a plurality of attribute-value pairs describing a set of products, semantic models including data describing relationships between product targets, concepts described using categories and attribute-value pairs, and target grouping data constituting a set of groupings of product targets, global performance data including performance data, wherein the processor is configured to identify at least one category in a portion of the product data, determine a product advertising structure based on the product data and the identified at least one category, match a portion of the groupings of product data with the product targets within the global performance data, identify performance data, and generate at least one product target using the identified performance data and the product data. | 09-18-2014 |
| Patent application number | Description | Published |
|---|
| 20160089651 | DE NOVO SYNTHESIZED GENE LIBRARIES - De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality genes. Devices for the manufacturing of large libraries of long and high-quality nucleic acids are further described herein. | 03-31-2016 |
| 20160090592 | DE NOVO SYNTHESIZED GENE LIBRARIES - De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality genes. Devices for the manufacturing of large libraries of long and high-quality nucleic acids are further described herein. | 03-31-2016 |
| 20160096160 | DE NOVO SYNTHESIZED GENE LIBRARIES - De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality genes. Devices for the manufacturing of large libraries of long and high-quality nucleic acids are further described herein. | 04-07-2016 |
| Patent application number | Description | Published |
|---|
| 20090010924 | Apoptotic Anti-IgE Antibodies - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 01-08-2009 |
| 20090028856 | Anti-CD79B Antibodies and Immunoconjugates and Methods of Use - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 01-29-2009 |
| 20090068202 | Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 03-12-2009 |
| 20100215669 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 08-26-2010 |
| 20110135667 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 06-09-2011 |
| 20120144512 | TRANSGENIC ANIMALS EXPRESSING HUMAN IGE-M1' - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 06-07-2012 |
| 20120148600 | Anti-CD79B Antibodies and Immunoconjugates and Methods of Use - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 06-14-2012 |
| 20120149881 | APOPTOTIC ANTI-IGE ANTIBODIES - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 06-14-2012 |
| 20120177635 | METHODS OF USING APOPTOTIC ANTI-IGE ANTIBODIES - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 07-12-2012 |
| 20120178127 | Nucleic acid encoding apoptotic anti-ige antibodies - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 07-12-2012 |
| 20140099260 | Anti-CD79B Antibodies and Immunoconjugates and Methods of Use - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 04-10-2014 |
| 20140115729 | APOPTOTIC ANTI-IGE ANTIBODIES - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 04-24-2014 |
| 20140335107 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 11-13-2014 |
| 20150314016 | ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE - The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same. | 11-05-2015 |
| Patent application number | Description | Published |
|---|
| 20090010925 | ANTIBODY VARIANTS - Antibody variants of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for the antigen. | 01-08-2009 |
| 20100047236 | ANTIBODY VARIANTS - Antibody variants of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for the antigen. | 02-25-2010 |
| 20100316596 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH CYTOKINE SIGNALING - Compositions and methods are provided for the diagnosis and treatment of inflammation and autoimmune disorders, such as psoriasis. Compositions and methods for modulating IL-23 or IL-22 signaling are provided. | 12-16-2010 |
| 20110182895 | ANTIBODY VARIANTS - Antibody variants of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for the antigen. | 07-28-2011 |
| 20130224146 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH CYTOKINE SIGNALING - Compositions and methods are provided for the diagnosis and treatment of inflammation and autoimmune disorders, such as psoriasis. Compositions and methods for modulating IL-23 or IL-22 signaling are provided. | 08-29-2013 |
| 20150284458 | ANTIBODY VARIANTS - Antibody variants of parent antibodies are disclosed which have one or more amino acids inserted in a hypervariable region of the parent antibody and a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for the antigen. | 10-08-2015 |
| Patent application number | Description | Published |
|---|
| 20080226629 | ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo. | 09-18-2008 |
| 20090011988 | METHOD FOR TREATING CARTILAGE DISORDERS - The present invention relates to a method for the treatment of a cartilage disorder, including cartilage damaged by injury or degenerative cartilagenous disorders. The method involves contacting the cartilage with an IGF-1 analog with altered affinity for IGF-binding proteins (IGFBPs) or an IGFBP displacer peptide that prevents the interaction of an IGF with an IGFBP and does not bind to a human IGF receptor. | 01-08-2009 |
| 20100130411 | METHOD FOR TREATING CARTILAGE DISORDERS - The present invention relates to a method for the treatment of a cartilage disorder, including cartilage damaged by injury or degenerative cartilagenous disorders. The method involves contacting the cartilage with an IGF-1 analog with altered affinity for IGF-binding proteins (IGFBPs) or an IGFBP displacer peptide that prevents the interaction of an IGF with an IGFBP and does not bind to a human IGF receptor. | 05-27-2010 |
| 20110052575 | ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo. | 03-03-2011 |
| 20110081342 | ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo. | 04-07-2011 |
| 20130058927 | ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo. | 03-07-2013 |
| 20150023951 | ANTI-VEGF ANTIBODIES - Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo. | 01-22-2015 |
